Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “Graves Disease”
Phase 3 2
- BHV-1300Biohaven Ltd.Graves Disease
- EfgartigimodARGENX SEGraves Disease
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.